Publication
Bromelain, a Group of Pineapple Proteolytic Complex Enzymes (Ananas comosus) and Their Possible Therapeutic and Clinical Effects. A Summary
| dc.contributor.author | Varilla, Carolina | |
| dc.contributor.author | Marcone, Massimo | |
| dc.contributor.author | Paiva, Lisete S. | |
| dc.contributor.author | Baptista, José | |
| dc.date.accessioned | 2022-03-24T17:19:40Z | |
| dc.date.available | 2022-03-24T17:19:40Z | |
| dc.date.issued | 2021-09-23 | |
| dc.date.updated | 2022-01-28T19:09:20Z | |
| dc.description.abstract | Bromelain is a complex combination of multiple endopeptidases of thiol and other compounds derived from the pineapple fruit, stem and/or root. Fruit bromelain and stem bromelain are produced completely distinctly and comprise unique compounds of enzymes, and the descriptor "Bromelain" originally referred in actuality to stem bromelain. Due to the efficacy of oral administration in the body, as a safe phytotherapeutic medication, bromelain was commonly suited for patients due to lack of compromise in its peptidase efficacy and the absence of undesired side effects. Various in vivo and in vitro studies have shown that they are anti-edematous, anti-inflammatory, anti-cancerous, anti-thrombotic, fibrinolytic, and facilitate the death of apoptotic cells. The pharmacological properties of bromelain are in part, related to its arachidonate cascade modulation, inhibition of platelet aggregation, such as interference with malignant cell growth; anti-inflammatory action; fibrinolytic activity; skin debridement properties, and reduction of the severe effects of SARS-Cov-2. In this paper, we concentrated primarily on the potential of bromelain's important characteristics and meditative and therapeutic effects, along with the possible mechanism of action. | en |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Varilla, C., Marcone, M., Paiva, L., & Baptista, J. (2021). Bromelain, a Group of Pineapple Proteolytic Complex Enzymes (Ananas comosus) and Their Possible Therapeutic and Clinical Effects. A Summary. “FOODS”, 10(10), 2249. https://doi.org/10.3390/foods10102249 | en |
| dc.identifier.doi | 10.3390/foods10102249 | pt_PT |
| dc.identifier.issn | 2304-8158 | |
| dc.identifier.pmc | PMC8534447 | |
| dc.identifier.pmid | 34681298 | |
| dc.identifier.slug | cv-prod-2687278 | |
| dc.identifier.uri | http://hdl.handle.net/10400.3/6253 | |
| dc.identifier.wos | 000712296100001 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | MDPI | pt_PT |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
| dc.subject | Ananas comosus | pt_PT |
| dc.subject | Bromelain | en |
| dc.subject | Proteinases | en |
| dc.subject | Pineapple Plant | en |
| dc.subject | Phytotherapeutic Applications | en |
| dc.subject | Anti-Inflammatory Effect | en |
| dc.subject | Clinical Use of Bromelain | en |
| dc.title | Bromelain, a Group of Pineapple Proteolytic Complex Enzymes (Ananas comosus) and Their Possible Therapeutic and Clinical Effects. A Summary | en |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.conferencePlace | Switzerland | en |
| oaire.citation.endPage | 14 | pt_PT |
| oaire.citation.issue | (10) | pt_PT |
| oaire.citation.startPage | 1 | pt_PT |
| oaire.citation.title | Foods | pt_PT |
| oaire.citation.volume | 10 | pt_PT |
| rcaap.cv.cienciaid | F015-95D2-365B | Lisete Sousa Paiva | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |